2023 Clinical Update and Memphis Eye Society Conference

Memphis, TN US
March 24, 2023 to March 25, 2023

The University of Tennessee Health Science Center (UTHSC) Hamilton Eye Institute’s 2023 Clinical Update and Memphis Eye Society Conference highlights our commitment to improving the health of our patients and the dissemination of medical knowledge to our community. This two-day conference will expand participants’ knowledge through the review and discussion of evidence-based medicine that supports the treatment of a number of eye diseases. Topics will be presented to address the individual physician gaps and will include current diagnosis, skills, and methodologies within the practice environment.

Target Audience

Ophthalmologists, Optometrists, Research Faculty, Residents, Medical Students

Learning Objectives

  • Discuss common pitfalls in patients with neuro-ophthalmology problems and how to avoid them
  • Identify strategies on the treatment of AMD in order to improve patient outcomes
  • Define the role of the Food and Drug Administration
  • (FDA) Ophthalmic Devices Panel

Additional Information

AttachmentSize
PDF icon 2023 Memphis Eye Society Conference Brochure-update.pdf509.44 KB
Course summary
Available credit: 
  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance
Course opens: 
02/23/2023
Course expires: 
03/26/2024
Event starts: 
03/24/2023 - 1:00pm CDT
Event ends: 
03/25/2023 - 2:05pm CDT
Add to calendar: 
 
 

2023 Clinical Update and Memphis Eye Society Conference

 
 Presentation #Friday, March 24, 2023 
Times PresentationSpeaker
12:00 PM - 1:00 PM Lunch 
1:00 PM - 1:05 PM Welcome/Opening RemarksMatthew Wilson, MD
1:05 PM - 1:50 PM1Schnyder Corneal Dystrophy - A Window into Insights on Cholesterol, Vitamin K, and Parkinson's DiseaseJayne Weiss, MD
1:50 PM - 1:55 PM Question and Answer 
1:55 PM - 2:40 PM2Character Development in Academic OphthalmologyR. Michael Siakowski, MD
2:40 PM - 2:45 PM Question and Answer 
2:45 PM - 3:00 PM Break 
3:00 PM - 5:00 PM ModeratorNawajes Mandal, PhD
    
3:20 PM - 3:40 PM4The BXD32 Inherited Retinal Dystrophy Phenotype is Induced by a Loss of Outer Segment MorphogenesisTJ Hollingsworth, PhD
3:40 PM - 4:00 PM5Our Journey with Pregabalin: A New Glaucoma MedicationMohamed Moustafa, PhD
4:00 PM - 4:20 PM6Alborz: A Humanoid Robot Under Training to Become a Digital OphthalmologistSiamak Yousefi, PhD
4:20 PM - 4:40 PM7Engineered Exosomes as Therapeutic Vehicles for Traumatic Brain InjuryRaja Shekhar Gangaraju, PhD
4:40 PM - 5:00 PM8Novel Lipid Mediators for Meibomian Gland Dysfunction and Dry EyeNawajes Mandal, PhD
 Presentation #Saturday, March 25, 2023 
Times PresentationSpeaker
8:00 AM - 8:05 AM Welcome/ModeratorMary Ellen Hoehn, MD
8:05 AM - 8:55 AM1Potential Pitfalls in Pediatric Neuro-OphthalmologyMichael Siatkowski, MD
8:55 AM - 9:00 AM Question and Answer 
9:00 AM - 9:15 AM2Update on Dry AMD: Emerging Therapeutics for Geographic AtrophyBenjamin King, MD
9:15 AM - 9:30 AM3MIGS: Tips and TricksClaire Wright, MD
9:30 AM - 9:45 AM4Update on OculoplasticsCynthia Noguera, MD
9:45 AM - 10:00 AM5What's New in the Treatment of Myopic ProgressionLor Sildiryan, MD
10:00 AM - 10:15 AM Break 
10:15 AM - 10:30 AM6Update on CorneaAaron Ashe, MD
10:30 AM - 10:45 AM7MIGS Complications and ManagementElliot Kanner, MD
10:45 AM - 11:00 AM8Alborz in Pediatric OphthalmologyMary Ellen Hoehn, MD
11:00 AM - 11:15 AM9Glaucoma Coding 2.0Brian Jerkins, MD
11:15 AM - 11:30 AM10New Trends in Management of Diabetic RetinopathySalar Rafieetry, MD
11:30 AM - 12:30 PM Lunch 
12:30 PM - 12:45 PM11Hamilton Eye Institute UpdateMatthew Wilson, MD
12:45 PM - 1:45 PM12Understanding the Corneal Dystrophies and the FDA Ophthalmic Devices Panel, Observations of a Panel MemberJayne Weiss, MD
1:45 PM - 2:00 PM Question and Answer 
2:00 PM - 2:05 PM Closing Remarks / AdjournMary Ellen Hoehn, MD

 

Memphis - Freeman Auditorium
930 Madison Ave
Hamilton Eye Institute
Memphis, TN 38163
United States

ACTIVITY MEDICAL DIRECTOR

Mary Ellen Hoehn, MD
Professor of Medicine
Department of Ophthalmology
UT Health Science Center

Speaker(s)

Sandip K Basu

has no relevant financial relationships to disclose at this time.

Raja Shekhar Gangaraju, MS, PhD

has no relevant financial relationships to disclose at this time.

TJ Hollingsworth, Bachelors of Science; Doctor of Philosophy

has a financial relationship (Independent contractor) with OculoTherapy, LLC;.

Elliott M Kanner, MD, PhD

has no relevant financial relationships to disclose at this time.

Ben King, MD

has no relevant financial relationships to disclose at this time.

Nawajes Mandal, Professor of Ophthalmology, Anatomy and Neurobiology

has no relevant financial relationships to disclose at this time.

Mohamed M I Moustafa

has no relevant financial relationships to disclose at this time.

Lorig Sildiryan

has no relevant financial relationships to disclose at this time.

Jayne Weiss, Jayne S Weiss MD, Chair LSU Department of Ophthalmology, Associate Dean of Clinical Affairs, Herbert E Kaufman MD Endowed Chair, Professor of Ophthalmology, Pathology and Pharmacology, LSUHSC, Chief Medical Officer, LSU Health Care Network. LSUHSC

has a financial relationship (Independent contractor) with Regeneron;.

Claire L Wright, MD

has no relevant financial relationships to disclose at this time.

Siamak Yousefi

has no relevant financial relationships to disclose at this time.

Available Credit

  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance
Please login or register to take this course.